In PAH, Nox2, and Nox4 are up-regulated (Green et al., 2012; Wedgwood et al., 2013) and implicated in the development of increased pulmonary artery resistance and pressure (Barman et al., 2014; Wu et al., 2017a). Here, CYBB is linked to pulmonary arterial hypertension.